text
"['\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2023.12.31\n)\n(단위 : 백만원, 천주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\n(주)비덴트\n상장\n2019.11.16\n단순투자\n55,001\n11,002\n18.58\n113,375\n15,436\n-\n17,741\n26,438\n34.25\n131,116\n637,860\n-16,287\n(주)하임바이오\n비상장\n2020.11.20\n사업다각화\n5,000\n3,975\n20.69\n\xa0 \xa0 \xa0 \xa0 \xa0-\n-\n-\n\xa0 \xa0 \xa0 \xa0 \xa0 -\n3,975\n18.70\n\xa0 \xa0 \xa0 \xa0 \xa0-\n4,892\n-1,472\nGenoplan Inc\n비상장\n2020.12.31\n사업다각화\n10,007\n233\n8.85\n-\n-\n-\n-\n233\n8.85\n-\n3,907\n-2,891\n쿼드콜라보 오퍼스2 투자조합\n비상장\n2022.06.07\n단순투자\n550\n-\n1.98\n486\n-\n-\n-10\n-\n0.5\n476\n46,821\n-1,200\n(주)리케어랩\n비상장\n2022년 09월 30일\n사업다각화\n240\n480\n48.0\n168\n-480\n65\n-103\n-\n-\n-\n-\n-\n합 계\n-\n-\n114,029\n14,956\n65\n17,628\n30,646\n-\n131,592\n-\n-\n']"
